An interventional study of Lifestyle Management in Tinnitus, Metabolic Syndrome X and Obesity, sponsored by Cairo University. Recruiting at 2 sites in Egypt. Open to participants aged 65 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-11-22.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The problem of tinnitus (subjective type) is prevalent in obese older adults with different diseases such as metabolic syndrome. The changes of lifestyle are very important to lose weight, improve tinnitus and metabolic syndrome
Sixty older adults (with metabolic syndrome with chronic subjective tinnitus) with obesity were selected in a equal random manner to be classified into the first group that administered changes in their lifestyle (exercise applied on treadmill and low caloric diet) for twelve successive weeks and second group that was not administered lifestyle changes
446 studies on the registry are indexed under Tinnitus; 98 are open to participants now.
This study's planned enrollment of 60 is close to the median of 60 across 370 interventional studies indexed under Tinnitus.
Browse Tinnitus studies →Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
thirty older adults (with obesity, metabolic syndrome, and chronic subjective tinnitus) administered supervised changes in their lifestyle (walking exercise for 40 minutes applied on treadmill for three time per week and low caloric diet) for twelve weeks
Behavioral: Lifestyle Management
thirty older adults (with obesity, metabolic syndrome, and chronic subjective tinnitus) served as control patients who did not receive any changes in their lifestyle
patients administered supervised changes in their lifestyle (walking exercise for 40 minutes applied on treadmill for three time per week and low caloric diet) for twelve weeks
visual analogue scale of tinnitus severity
it is scale (10 cm) that will assess severity of tinnitus
Time frame: twelve weeks
visual analogue scale of tinnitus related discomfort
it is a scale (10 cm) that will assess tinnitus related discomfort
Time frame: twelve weeks
tinnitus handicap inventory
it is a questionnaire that will assess quality of life in tinnitus population
Time frame: twelve weeks
body mass index
it will be assessed at morning after evacuation of bowel and bladder
Time frame: twelve weeks
waist circumference
it will be measured at the level of umbilicus
Time frame: twelve weeks
triglycerides
it will be measured in the serum
Time frame: twelve weeks
high density lipoprotein
it will be assessed in the serum
Time frame: twelve weeks
systolic blood pressure
it will be assessed by mercury sphygmomnameter
Time frame: twelve weeks
diastolic blood pressure
it will be assessed by mercury sphygmomnameter
Time frame: twelve weeks
fasting blood glucose
it will be measured in serum
Time frame: twelve weeks
Started Jan 2024 (actual). Primary completion is estimated for Jan 2025, 12 months after the start.
Of 134 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 12 months is below that.
Counting every sponsor, half of 153 studies reached it within 17 months; a quarter within 10 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.